Author Correction: Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknesses

Affiliations

• ¹ Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA.
• ² The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
• ³ Massachusetts General Hospital Cancer Center, Charlestown, MA, USA.
• ⁴ Harvard Medical School, Boston, MA, USA.
• ⁵ Agios Pharmaceutical, Cambridge, MA, USA.
• ⁶ Berlin Institute for Medical Systems Biology, Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
• ⁷ Department of Nanobiotechnology, Vision Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
• ⁸ Department of Pathology, Stanford University, Stanford, CA, USA.
• ⁹ Center for Genomics and Systems Biology, Department of Biology, New York University, New York, USA.
• ¹⁰ IRI Life Sciences, Institute für Biologie, Humboldt Universität zu Berlin, Berlin, Germany.
• ¹¹ Core Unit Bioinformatics, Berlin Institute of Health (BIH), Berlin, Germany.
• ¹² Massachusetts General Hospital Cancer Center, Charlestown, MA, USA. dyson@helix.mgh.harvard.edu.
• ¹³ Harvard Medical School, Boston, MA, USA. dyson@helix.mgh.harvard.edu.
• ¹⁴ Department of Cancer Biology and Genetics, The Ohio State University, Columbus, OH, USA. wayne.miles@osumc.edu.
• ¹⁵ The Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA. wayne.miles@osumc.edu.